Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel Implant PK in HIV-Infected Women on Rilpivirine or Darunavir
NCT03589027Phase 2Unknown
- Sponsor
- Makerere University
- Start
- Aug 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of avatrombopag in contraception (2 arms), sponsored by Makerere University. Primary endpoint: Mean Levonorgestrel concentrations at 6 months. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03589027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589027.